Tcr2 Therapeutics Stock Price, News & Analysis
Company Description
Tcr2 Therapeutics (NASDAQ: TCRR) is a publicly traded biological product (except diagnostic) manufacturing company in the Manufacturing sector. The company has a market capitalization of $58.1M.
TCRR stock has declined 36.2% over the past year.
This page provides a comprehensive overview of TCRR stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Tcr2 Therapeutics (TCRR) stock. Over the past 12 months, the stock has lost 36.2%. At a market capitalization of $58.1M, TCRR is classified as a micro-cap stock with approximately 39.3M shares outstanding.
Latest News
Tcr2 Therapeutics has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, conferences. View all TCRR news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
TCRR Company Profile & Sector Positioning
Tcr2 Therapeutics (TCRR) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.